A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)

NCT03720548 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: LY3372993
DRUG: Placebo

Sponsor

Eli Lilly and Company